Safely obtaining adequate exposure is an integral step in successfully performing a Total Knee Arthroplasty. In this study, we look at approaching the valgus knee through a lateral arthrotomy and tibial tubercle osteotomy. 20 knees in 19 consecutive patients with valgus deformities are included in this study (2006 to 2010). LCS mobile bearing prostheses were implanted by a single senior surgeon (GF). Navigation was used for all the knees. The knee is approached throught a skin incision 5–10mm more lateral than the standard midline incision. The lateral arthrotomy is made to Gerdy's tubercle 7–10cm distal to Tibial Tendon insertion. 7cm long and 2cm wide osteotomy is performed. Richards staples are used to fix the osteotomy once the prosthesis is fixed. All patients were followed up by the operating surgeon. All osteotomies united. 2 postoperative complications were encountered during follow up. One patient had a postoperative haematoma that was washed out. A second patient had a fall 6/52 post-op and sustained a minimally displaced fracture at the navigation pin site (Tibia). This was treated in a cylinder cast and went onto full union. Our technique of lateral arthrotomy and TTO in the valgus knee is safe and predictable. It delivers wider exposure, facilitates soft tissue management, preserves viability of the extensor mechanism and allows some movement of the tibial tubercle for improved patella tracking. We recommend planning this procedure preoperatively for best results.
Diphosphonates remain among the most common drug treatments for osteoporosis. Recent evidence has implicated diphosphonate therapy, specifically, alendronate, with low-energy fractures of the subtrochanteric region of the femur. The general conclusion is that prolonged suppression of bone remodelling with alendronate may be associated with a new form of insufficiency fracture of the femur. Three case reports of patients with alendronate related insufficiency are discussed here with their treatment modalities and lessons learnt. One of the three patients had bilateral subtrochanteric stress fracture. A comprehensive review of the literature is presented with the best evidence for investigating, treating and preventing these fractures Our experience in Launceston has increased awareness amongst the local medical community regarding the long term use of Diphosphnates and the fractures they may cause. Changes to our practice have included: Increased suspicion of patients with hip pain on diphosphonate therapy, imaging the contralateral femur to rule out stress fractures, reassuring GP's and Patients that benefits of Diphosphonate therapy far outweigh the potential risks. There are many unresolved questions about the prolonged use of diphosphonates, but there is sufficient evidence to show subtrochanteric stress fractures do occur. We, as Orthopaedic Surgeons, must be able to recognize this new entity and educate our medical colleagues appropriately.
